| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Chief Medical Officer | Class A Common Stock | 121,110 | $1,280,811 | $10.58 | 16 May 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS, INC. | 16 May 2022 | 1 | -$4,717 | 4 | Chief Medical Officer | 18 May 2022, 19:19 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | 31 Mar 2022 | 2 | +$22,499 | 4 | Chief Medical Officer | 04 Apr 2022, 16:06 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | 28 Feb 2022 | 2 | +$38,750 | 4 | Chief Medical Officer | 01 Mar 2022, 19:00 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | 04 Feb 2022 | 5 | -$11,183 | 4 | Chief Medical Officer | 08 Feb 2022, 20:09 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | 31 Jan 2022 | 2 | +$38,750 | 4 | Chief Medical Officer | 02 Feb 2022, 19:11 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | 03 Jan 2022 | 2 | +$99,595 | 4 | Chief Medical Officer | 05 Jan 2022, 19:48 |